Ingrid E Wertz

ORCID

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 12

Top Venues

American journal of hematology

Nature chemical biology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Elisabeth A Lasater, Dhara N Amin, Rajat Bannerji, Raghuveer Singh Mali, Kathy Barrett, Ryan N Rys, Jason Oeh, Eva Lin, Tim Sterne-Weiler, Ellen Rei Ingalla, MaryAnn Go, Shang-Fan Yu, Maxwell M Krem, Chris Arthur, Uwe Hahn, Anna Johnston, Vinit Karur, Nadia Khan, Paula Marlton, Tycel Jovelle Phillips, Giuseppe Gritti, John F Seymour, Monica Tani, Sam Yuen, Scott Martin, Matthew T Chang, Christopher M Rose, Victoria C Pham, Andrew G Polson, YiMeng Chang, Claudia Wever, Nathalie A Johnson, Yanwen Jiang, Jamie Hirata, Deepak Sampath, Lisa Musick, Christopher R Flowers, Ingrid E Wertz
Targeting MCL-1 and BCL-2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non-Hodgkin lymphoma: Results from preclinical models and a Phase Ib study. American journal of hematology 98 (3) (2023)
Elisabeth A Lasater, Dhara N Amin, Rajat Bannerji, Raghuveer Singh Mali, Kathy Barrett, Ryan N Rys, Jason Oeh, Eva Lin, Tim Sterne-Weiler, Ellen Rei Ingalla, MaryAnn Go, Shang-Fan Yu, Maxwell M Krem, Chris Arthur, Uwe Hahn, Anna Johnston, Vinit Karur, Nadia Khan, Paula Marlton, Tycel Jovelle Phillips, Giuseppe Gritti, John F Seymour, Monica Tani, Sam Yuen, Scott Martin, Matthew T Chang, Christopher M Rose, Victoria C Pham, Andrew G Polson, YiMeng Chang, Claudia Wever, Nathalie A Johnson, Yanwen Jiang, Jamie Hirata, Deepak Sampath, Lisa Musick, Christopher R Flowers, Ingrid E Wertz
Targeting MCL-1 and BCL-2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non-Hodgkin lymphoma: Results from preclinical models and a Phase Ib study. American journal of hematology (2023)
Elisabeth A Lasater, Dhara N Amin, Rajat Bannerji, Raghuveer Singh Mali, Kathy Barrett, Ryan N Rys, Jason Oeh, Eva Lin, Tim Sterne-Weiler, Ellen Rei Ingalla, MaryAnn Go, Shang-Fan Yu, Maxwell M Krem, Chris Arthur, Uwe Hahn, Anna Johnston, Vinit Karur, Nadia Khan, Paula Marlton, Tycel Jovelle Phillips, Giuseppe Gritti, John F Seymour, Monica Tani, Sam Yuen, Scott Martin, Matthew T Chang, Christopher M Rose, Victoria C Pham, Andrew G Polson, YiMeng Chang, Claudia Wever, Nathalie A Johnson, Yanwen Jiang, Jamie Hirata, Deepak Sampath, Lisa Musick, Christopher R Flowers, Ingrid E Wertz
Targeting MCL-1 and BCL-2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non-Hodgkin lymphoma: Results from preclinical models and a Phase Ib study. American journal of hematology 98 (3) (2023)
Elisabeth A Lasater, Dhara N Amin, Rajat Bannerji, Raghuveer Singh Mali, Kathy Barrett, Ryan N Rys, Jason Oeh, Eva Lin, Tim Sterne-Weiler, Ellen Rei Ingalla, MaryAnn Go, Shang-Fan Yu, Maxwell M Krem, Chris Arthur, Uwe Hahn, Anna Johnston, Vinit Karur, Nadia Khan, Paula Marlton, Tycel Jovelle Phillips, Giuseppe Gritti, John F Seymour, Monica Tani, Sam Yuen, Scott Martin, Matthew T Chang, Christopher M Rose, Victoria C Pham, Andrew G Polson, YiMeng Chang, Claudia Wever, Nathalie A Johnson, Yanwen Jiang, Jamie Hirata, Deepak Sampath, Lisa Musick, Christopher R Flowers, Ingrid E Wertz
Targeting MCL-1 and BCL-2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non-Hodgkin lymphoma: Results from preclinical models and a Phase Ib study. American journal of hematology 98 (3) (2023)
Elisabeth A Lasater, Dhara N Amin, Rajat Bannerji, Raghuveer Singh Mali, Kathy Barrett, Ryan N Rys, Jason Oeh, Eva Lin, Tim Sterne-Weiler, Ellen Rei Ingalla, MaryAnn Go, Shang-Fan Yu, Maxwell M Krem, Chris Arthur, Uwe Hahn, Anna Johnston, Vinit Karur, Nadia Khan, Paula Marlton, Tycel Jovelle Phillips, Giuseppe Gritti, John F Seymour, Monica Tani, Sam Yuen, Scott Martin, Matthew T Chang, Christopher M Rose, Victoria C Pham, Andrew G Polson, YiMeng Chang, Claudia Wever, Nathalie A Johnson, Jiang Yanwen, Jamie Hirata, Deepak Sampath, Lisa Musick, Christopher R Flowers, Ingrid E Wertz
Targeting MCL-1 and BCL-2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R NHL: Results from preclinical models and a Phase Ib study. American journal of hematology (2023)
Elisabeth A Lasater, Dhara N Amin, Rajat Bannerji, Raghuveer Singh Mali, Kathy Barrett, Ryan N Rys, Jason Oeh, Eva Lin, Tim Sterne-Weiler, Ellen Rei Ingalla, MaryAnn Go, Shang-Fan Yu, Maxwell M Krem, Chris Arthur, Uwe Hahn, Anna Johnston, Vinit Karur, Nadia Khan, Paula Marlton, Tycel Jovelle Phillips, Giuseppe Gritti, John F Seymour, Monica Tani, Sam Yuen, Scott Martin, Matthew T Chang, Christopher M Rose, Victoria C Pham, Andrew G Polson, YiMeng Chang, Claudia Wever, Nathalie A Johnson, Yanwen Jiang, Jamie Hirata, Deepak Sampath, Lisa Musick, Christopher R Flowers, Ingrid E Wertz
Targeting MCL-1 and BCL-2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non-Hodgkin lymphoma: Results from preclinical models and a Phase Ib study. American journal of hematology 98 (3) (2023)
Charlene Bashore, Sumit Prakash, Matthew C Johnson, Ryan J Conrad, Ivy A Kekessie, Suzie J Scales, Noriko Ishisoko, Tracy Kleinheinz, Peter S Liu, Nataliya Popovych, Aaron T Wecksler, Lijuan Zhou, Christine Tam, Inna Zilberleyb, Rajini Srinivasan, Robert A Blake, Aimin Song, Steven T Staben, Yingnan Zhang, David Arnott, Wayne J Fairbrother, Scott A Foster, Ingrid E Wertz, Claudio Ciferri, Erin C Dueber
Targeted degradation via direct 26S proteasome recruitment. Nature chemical biology 19 (1) (2022)
Charlene Bashore, Sumit Prakash, Matthew C Johnson, Ryan J Conrad, Ivy A Kekessie, Suzie J Scales, Noriko Ishisoko, Tracy Kleinheinz, Peter S Liu, Nataliya Popovych, Aaron T Wecksler, Lijuan Zhou, Christine Tam, Inna Zilberleyb, Rajini Srinivasan, Robert A Blake, Aimin Song, Steven T Staben, Yingnan Zhang, David Arnott, Wayne J Fairbrother, Scott A Foster, Ingrid E Wertz, Claudio Ciferri, Erin C Dueber
Targeted degradation via direct 26S proteasome recruitment. Nature chemical biology 19 (1) (2022)
Charlene Bashore, Sumit Prakash, Matthew C Johnson, Ryan J Conrad, Ivy A Kekessie, Suzie J Scales, Noriko Ishisoko, Tracy Kleinheinz, Peter S Liu, Nataliya Popovych, Aaron T Wecksler, Lijuan Zhou, Christine Tam, Inna Zilberleyb, Rajini Srinivasan, Robert A Blake, Aimin Song, Steven T Staben, Yingnan Zhang, David Arnott, Wayne J Fairbrother, Scott A Foster, Ingrid E Wertz, Claudio Ciferri, Erin C Dueber
Targeted degradation via direct 26S proteasome recruitment. Nature chemical biology 19 (1) (2022)
Charlene Bashore, Sumit Prakash, Matthew C Johnson, Ryan J Conrad, Ivy A Kekessie, Suzie J Scales, Noriko Ishisoko, Tracy Kleinheinz, Peter S Liu, Nataliya Popovych, Aaron T Wecksler, Lijuan Zhou, Christine Tam, Inna Zilberleyb, Rajini Srinivasan, Robert A Blake, Aimin Song, Steven T Staben, Yingnan Zhang, David Arnott, Wayne J Fairbrother, Scott A Foster, Ingrid E Wertz, Claudio Ciferri, Erin C Dueber
Targeted degradation via direct 26S proteasome recruitment. Nature chemical biology 19 (1) (2022)
Charlene Bashore, Sumit Prakash, Matthew C Johnson, Ryan J Conrad, Ivy A Kekessie, Suzie J Scales, Noriko Ishisoko, Tracy Kleinheinz, Peter S Liu, Nataliya Popovych, Aaron T Wecksler, Lijuan Zhou, Christine Tam, Inna Zilberleyb, Rajini Srinivasan, Robert A Blake, Aimin Song, Steven T Staben, Yingnan Zhang, David Arnott, Wayne J Fairbrother, Scott A Foster, Ingrid E Wertz, Claudio Ciferri, Erin C Dueber
Targeted degradation via direct 26S proteasome recruitment. Nature chemical biology 19 (1) (2022)
Christopher W Davies, Simon E Vidal, Lilian Phu, Jawahar Sudhamsu, Trent B Hinkle, Scott Chan Rosenberg, Frances-Rose Schumacher, Yi Jimmy Zeng, Carsten Schwerdtfeger, Andrew S Peterson, Jennie R Lill, Christopher M Rose, Andrey S Shaw, Ingrid E Wertz, Donald S Kirkpatrick, James T Koerber
Antibody toolkit reveals N-terminally ubiquitinated substrates of UBE2W. Nature communications 12 (1) (2021)

Ingrid E Wertz.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ingrid E Wertz